SEC
|
McCourt Marion
|
EVP Commercial
|
|
-1K
|
$844.61
|
-$844.61K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-1K
|
$1.05K
|
-$1.05M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$1.05K
|
-$104.88K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-1K
|
$1.18K
|
-$1.18M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$1.18K
|
-$117.87K
|
|
SEC
|
Fenimore Christopher R.
|
SVP Finance & CFO
|
|
-5.7K
|
$1.21K
|
-$6.85M
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-756
|
$1.17K
|
-$884.52K
|
|
SEC
|
POON CHRISTINE A
|
N/A
|
|
-11K
|
$1.16K
|
-$12.55M
|
|
SEC
|
MURPHY ANDREW J
|
EVP Research
|
|
-6.4K
|
$1.15K
|
-$7.34M
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
-5.2K
|
$1.08K
|
-$5.64M
|
|
SEC
|
Pitofsky Jason
|
VP Controller
|
|
-487
|
$1.07K
|
-$521.09K
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-756
|
$1.12K
|
-$842.94K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-1.1K
|
$1.06K
|
-$1.21M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$1.10K
|
-$110.00K
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
-1.9K
|
$1.09K
|
-$2.03M
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-1.1K
|
$1.05K
|
-$1.19M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$1.06K
|
-$105.92K
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-756
|
$1.06K
|
-$802.87K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-1.5K
|
$1.04K
|
-$1.60M
|
|
SEC
|
SCHLEIFER LEONARD S
|
Bd. Co-Chair, President & CEO
|
|
-25K
|
$1.02K
|
-$25.61M
|
|
SEC
|
SCHLEIFER LEONARD S
|
Bd. Co-Chair, President & CEO
|
|
-787
|
$1.02K
|
-$798.82K
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-827
|
$1.01K
|
-$836.10K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-1.1K
|
$980.16
|
-$1.12M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$994.50
|
-$99.45K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-1.2K
|
$974.86
|
-$1.14M
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
-1.9K
|
$994.90
|
-$1.86M
|
|
SEC
|
SCHLEIFER LEONARD S
|
Bd. Co-Chair, President & CEO
|
|
-23K
|
$979.23
|
-$22.36M
|
|
SEC
|
YANCOPOULOS GEORGE
|
Bd. Co-Chair, President & CSO
|
|
-50K
|
$972.73
|
-$48.64M
|
|
SEC
|
SCHLEIFER LEONARD S
|
Bd. Co-Chair, President & CEO
|
|
-36K
|
$979.58
|
-$35.21M
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-250
|
$889.41
|
-$222.35K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$899.61
|
-$89.96K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-250
|
$964.73
|
-$241.18K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$962.53
|
-$96.25K
|
|
SEC
|
MURPHY ANDREW J
|
EVP Research
|
|
-5.8K
|
$956.47
|
-$5.53M
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-358
|
$967.50
|
-$346.37K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$982.05
|
-$98.21K
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-854
|
$979.25
|
-$836.28K
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
-1K
|
$990.00
|
-$990.00K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-1K
|
$992.50
|
-$992.50K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-3.5K
|
$967.86
|
-$3.39M
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
-1K
|
$967.65
|
-$967.65K
|
|
SEC
|
Van Plew Daniel P
|
EVP & General Mgr, Industrial
|
|
-10K
|
$942.28
|
-$9.83M
|
|
SEC
|
Fenimore Christopher R.
|
SVP Finance & CFO
|
|
-4.9K
|
$953.31
|
-$4.69M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-1K
|
$950.00
|
-$950.00K
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
-1K
|
$950.00
|
-$950.00K
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
-8K
|
$950.35
|
-$7.64M
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-1K
|
$934.71
|
-$934.71K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-273
|
$945.61
|
-$258.15K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$954.22
|
-$95.42K
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-827
|
$959.00
|
-$793.09K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2.7K
|
$950.00
|
-$2.57M
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-826
|
$914.00
|
-$754.96K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-274
|
$873.91
|
-$239.45K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$899.90
|
-$89.99K
|
|
SEC
|
YANCOPOULOS GEORGE
|
Bd. Co-Chair, President & CSO
|
|
-34K
|
$900.00
|
-$30.33M
|
|
SEC
|
Zoghbi Huda Y
|
N/A
|
|
-1.1K
|
$900.00
|
-$1.01M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-2K
|
$898.00
|
-$1.84M
|
|
SEC
|
Fenimore Christopher R.
|
SVP Controller
|
|
-2.4K
|
$856.71
|
-$2.10M
|
|
SEC
|
Fenimore Christopher R.
|
SVP Controller
|
|
-1.9K
|
$844.30
|
-$1.63M
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-610
|
$870.00
|
-$530.70K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-270
|
$838.44
|
-$226.38K
|
|
SEC
|
MURPHY ANDREW J
|
EVP Research
|
|
-6.5K
|
$817.44
|
-$5.34M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$817.30
|
-$81.73K
|
|
SEC
|
MURPHY ANDREW J
|
EVP Research
|
|
-6.5K
|
$799.17
|
-$5.19M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$827.90
|
-$82.79K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-1K
|
$783.91
|
-$783.91K
|
|
SEC
|
Zoghbi Huda Y
|
N/A
|
|
-1K
|
$850.00
|
-$850.00K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-1K
|
$827.00
|
-$858.43K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-250
|
$834.55
|
-$208.64K
|
|
SEC
|
Van Plew Daniel P
|
EVP & General Mgr, Industrial
|
|
-6.2K
|
$841.71
|
-$5.22M
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-223
|
$844.00
|
-$188.21K
|
|
SEC
|
POON CHRISTINE A
|
N/A
|
|
-12K
|
$839.97
|
-$10.31M
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
-12K
|
$840.98
|
-$9.81M
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-853
|
$829.00
|
-$707.14K
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-853
|
$789.00
|
-$673.02K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-250
|
$744.66
|
-$186.17K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$736.59
|
-$73.66K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-250
|
$710.09
|
-$177.52K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$716.88
|
-$71.69K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-250
|
$736.00
|
-$184.00K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$735.42
|
-$73.54K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$805.33
|
-$80.53K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-3.1K
|
$798.42
|
-$2.45M
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-1.1K
|
$818.80
|
-$900.68K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$819.31
|
-$81.93K
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-1.2K
|
$823.20
|
-$979.61K
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-1.2K
|
$818.00
|
-$1.01M
|
|
SEC
|
Fenimore Christopher R.
|
SVP Controller
|
|
-2.2K
|
$806.47
|
-$1.77M
|
|
SEC
|
YANCOPOULOS GEORGE
|
President and Chief Scientific
|
|
-3.7K
|
$804.26
|
-$2.94M
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-1.1K
|
$759.89
|
-$835.88K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$762.50
|
-$76.25K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-500
|
$669.39
|
-$334.70K
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-739
|
$600.17
|
-$443.53K
|
|
SEC
|
YANCOPOULOS GEORGE
|
President and Chief Scientific
|
|
-13K
|
$800.08
|
-$10.55M
|
|
SEC
|
Fenimore Christopher R.
|
SVP Controller
|
|
+1.7K
|
$470.25
|
+$806.01K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$756.13
|
-$75.61K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
+65
|
$274.07
|
+$17.81K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-264
|
$730.17
|
-$192.76K
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-218
|
$779.00
|
-$169.82K
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-610
|
$756.66
|
-$461.56K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$758.17
|
-$75.82K
|
|
SEC
|
MURPHY ANDREW J
|
EVP Research
|
|
-1.4K
|
$429.95
|
-$584.73K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-500
|
$595.48
|
-$297.74K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$755.89
|
-$75.59K
|
|
SEC
|
Fenimore Christopher R.
|
SVP Controller
|
|
-1.8K
|
$749.00
|
-$1.38M
|
|
SEC
|
Fenimore Christopher R.
|
SVP Controller
|
|
-3.3K
|
$724.00
|
-$2.42M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$726.54
|
-$72.65K
|
|
SEC
|
Bassler Bonnie L
|
N/A
|
|
-3.2K
|
$704.65
|
-$2.23M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$582.37
|
-$58.24K
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
-335
|
$440.89
|
-$147.70K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-2.5K
|
$462.02
|
-$1.16M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$650.78
|
-$65.08K
|
|
SEC
|
Fenimore Christopher R.
|
SVP Controller
|
|
+1.8K
|
$523.95
|
+$966.16K
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
-5.1K
|
$721.10
|
-$3.69M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-7.1K
|
$710.05
|
-$5.05M
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
-5.1K
|
$690.73
|
-$3.53M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$692.81
|
-$69.28K
|
|
SEC
|
Fenimore Christopher R.
|
SVP Controller
|
|
+3.3K
|
$478.45
|
+$1.60M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-2.9K
|
$710.01
|
-$2.05M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-1.9K
|
$699.00
|
-$1.35M
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
-29K
|
$700.01
|
-$20.00M
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-2.7K
|
$687.90
|
-$1.85M
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-212
|
$569.52
|
-$120.74K
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-304
|
$575.08
|
-$174.82K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$618.37
|
-$61.84K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-4K
|
$618.25
|
-$2.47M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-500
|
$608.68
|
-$304.34K
|
|
SEC
|
Van Plew Daniel P
|
EVP & General Mgr, Industrial
|
|
-6.8K
|
$613.99
|
-$4.16M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$607.14
|
-$60.71K
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
+27K
|
$365.19
|
+$9.82M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
+91
|
$214.76
|
+$19.54K
|
|
SEC
|
YANCOPOULOS GEORGE
|
President and Chief Scientific
|
|
+132K
|
$381.39
|
+$50.41M
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
-126
|
$634.98
|
-$80.01K
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-697
|
$620.19
|
-$432.27K
|
|
SEC
|
McCourt Marion
|
EVP Commercial
|
|
-732
|
$659.07
|
-$482.44K
|
|
SEC
|
Fenimore Christopher R.
|
SVP Controller
|
|
-270
|
$664.34
|
-$179.37K
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
-697
|
$664.34
|
-$463.04K
|
|
SEC
|
MURPHY ANDREW J
|
EVP Research
|
|
-697
|
$664.34
|
-$463.04K
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
-753
|
$664.34
|
-$500.25K
|
|
SEC
|
Van Plew Daniel P
|
EVP & General Mgr, Industrial
|
|
-697
|
$664.34
|
-$463.04K
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
+4K
|
$360.72
|
+$1.43M
|
|
SEC
|
MURPHY ANDREW J
|
EVP Research
|
|
+3.5K
|
$322.69
|
+$1.12M
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
+14K
|
$345.82
|
+$4.69M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-600
|
$106.25
|
-$63.75K
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
+40K
|
$339.48
|
+$13.47M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-3K
|
$656.67
|
-$1.97M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
+161K
|
$397.04
|
+$63.99M
|
|
SEC
|
MURPHY ANDREW J
|
EVP Research
|
|
-1.6K
|
$331.54
|
-$545.38K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-21K
|
$653.76
|
-$13.57M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$642.52
|
-$64.25K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$569.49
|
-$56.95K
|
|
SEC
|
Zoghbi Huda Y
|
N/A
|
|
-1K
|
$650.00
|
-$650.00K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-9.7K
|
$648.16
|
-$6.29M
|
|
SEC
|
Tessier-Lavigne Marc
|
N/A
|
|
-13K
|
$641.71
|
-$8.18M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$676.28
|
-$67.63K
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
+83
|
$612.77
|
+$50.86K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-2.7K
|
$672.00
|
-$1.81M
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
+26K
|
$372.74
|
+$9.59M
|
|
SEC
|
Fenimore Christopher R.
|
SVP Controller
|
|
+8.7K
|
$303.66
|
+$2.65M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-410K
|
$650.03
|
-$266.51M
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
-127K
|
$94.77
|
-$12.02M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-10K
|
$624.36
|
-$6.24M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-2.4K
|
$630.00
|
-$1.52M
|
|
SEC
|
YANCOPOULOS GEORGE
|
President and Chief Scientific
|
|
-50K
|
$625.29
|
-$31.26M
|
|
SEC
|
COLES N ANTHONY
|
N/A
|
|
-2K
|
$625.00
|
-$1.25M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-7.3K
|
$617.71
|
-$4.51M
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-901
|
$614.30
|
-$553.48K
|
|
SEC
|
Van Plew Daniel P
|
EVP & General Mgr, Industrial
|
|
-6.6K
|
$611.86
|
-$4.04M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-1.7K
|
$612.38
|
-$1.03M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-14K
|
$612.35
|
-$8.30M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$577.95
|
-$57.80K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$564.50
|
-$56.45K
|
|
SEC
|
YANCOPOULOS GEORGE
|
President and Chief Scientific
|
|
-100K
|
$600.06
|
-$60.01M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$524.76
|
-$52.48K
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
+171K
|
$254.02
|
+$43.55M
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
-435
|
$331.87
|
-$144.36K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$506.92
|
-$50.69K
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
+112K
|
$196.59
|
+$22.02M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
+148
|
$138.97
|
+$20.57K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$520.48
|
-$52.05K
|
|
SEC
|
COLES N ANTHONY
|
N/A
|
|
+11
|
$345.47
|
+$3.80K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-4.6K
|
$11.92
|
-$54.83K
|
|
SEC
|
MURPHY ANDREW J
|
EVP Research
|
|
+5.2K
|
$38.56
|
+$199.93K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$558.13
|
-$55.81K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-2K
|
$434.47
|
-$868.94K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$604.58
|
-$60.46K
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
-4.7K
|
$615.04
|
-$2.87M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-10K
|
$612.06
|
-$6.12M
|
|
SEC
|
POON CHRISTINE A
|
N/A
|
|
-40K
|
$601.22
|
-$24.05M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-21K
|
$515.91
|
-$10.83M
|
|
SEC
|
Van Plew Daniel P
|
EVP & General Mgr Industrial O
|
|
-27K
|
$610.89
|
-$16.56M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-31K
|
$444.55
|
-$13.78M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-1K
|
$617.18
|
-$617.18K
|
|
SEC
|
Van Plew Daniel P
|
EVP & General Mgr Industrial O
|
|
+27K
|
$348.64
|
+$9.45M
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
-107K
|
$188.72
|
-$20.17M
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-696
|
$654.46
|
-$455.50K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$641.93
|
-$64.19K
|
|
SEC
|
YANCOPOULOS GEORGE
|
President and Chief Scientific
|
|
+305K
|
$186.64
|
+$56.94M
|
|
SEC
|
Fenimore Christopher R.
|
VP Controller
|
|
+2.2K
|
$378.53
|
+$841.85K
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
+696
|
$569.81
|
+$396.59K
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-579
|
$640.50
|
-$370.85K
|
|
SEC
|
MURPHY ANDREW J
|
EVP Research
|
|
-14K
|
$626.98
|
-$8.97M
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
+579
|
$508.09
|
+$294.18K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-11K
|
$650.05
|
-$6.83M
|
|
SEC
|
Zoghbi Huda Y
|
N/A
|
|
-1.7K
|
$650.00
|
-$1.11M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$609.70
|
-$60.97K
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-400
|
$612.57
|
-$245.03K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-3K
|
$608.91
|
-$1.83M
|
|
SEC
|
Fenimore Christopher R.
|
VP Controller
|
|
+2.2K
|
$282.68
|
+$616.24K
|
|
SEC
|
Sanofi
|
N/A
|
|
-120K
|
$597.48
|
-$71.84M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$603.23
|
-$60.32K
|
|
SEC
|
Sanofi
|
N/A
|
|
-23M
|
$509.85
|
-$11.64B
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-2K
|
$587.76
|
-$1.18M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-1K
|
$578.94
|
-$578.94K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
+4K
|
$297.46
|
+$1.20M
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
-8.4K
|
$572.00
|
-$4.79M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-850
|
$327.73
|
-$278.57K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2K
|
$560.00
|
-$1.12M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-100
|
$520.37
|
-$52.04K
|
|
SEC
|
LAROSA JOSEPH J
|
EVP General Counsel and Secret
|
|
+0
|
$570.30
|
+$0.00
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
-5.5K
|
$521.07
|
-$2.86M
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-788
|
$494.49
|
-$389.66K
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
+188
|
$379.89
|
+$71.42K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-1.8K
|
$254.03
|
-$452.17K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-200
|
$475.27
|
-$95.05K
|
|
SEC
|
Sanofi
|
N/A
|
|
-129K
|
$489.65
|
-$63.12M
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
-10K
|
$452.26
|
-$4.68M
|
|
SEC
|
Landry Robert E
|
EVP Finance CFO
|
|
-414
|
$452.49
|
-$187.33K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-2.4K
|
$313.56
|
-$752.54K
|
|
SEC
|
Van Plew Daniel P
|
EVP & General Mgr Industrial O
|
|
-16K
|
$457.23
|
-$7.15M
|
|
SEC
|
YANCOPOULOS GEORGE
|
President and Chief Scientific
|
|
-118K
|
$420.17
|
-$49.63M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-1K
|
$382.83
|
-$382.83K
|
|
SEC
|
MURPHY ANDREW J
|
EVP Research
|
|
-8K
|
$340.91
|
-$2.73M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
+320
|
$196.10
|
+$62.75K
|
|
SEC
|
Fenimore Christopher R.
|
VP Controller
|
|
+400
|
$30.63
|
+$12.25K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-126
|
$375.31
|
-$47.29K
|
|
SEC
|
Fenimore Christopher R.
|
VP Controller
|
|
+3.5K
|
$136.70
|
+$481.18K
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
+150K
|
$142.77
|
+$21.48M
|
|
SEC
|
YANCOPOULOS GEORGE
|
President and CSO
|
|
+116K
|
$21.46
|
+$2.48M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-1K
|
$280.20
|
-$280.20K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-1K
|
$340.44
|
-$340.44K
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
-8.7K
|
$287.73
|
-$2.49M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-85K
|
$99.23
|
-$8.48M
|
|
SEC
|
Sanofi
|
N/A
|
|
-173K
|
$281.15
|
-$48.61M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-1K
|
$305.93
|
-$305.93K
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
-9.9K
|
$305.74
|
-$3.01M
|
|
SEC
|
Fenimore Christopher R.
|
VP Controller
|
|
+350
|
$7.08
|
+$2.48K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
+73K
|
$120.88
|
+$8.77M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
+100
|
$21.25
|
+$2.13K
|
|
SEC
|
Sanofi
|
N/A
|
|
-131K
|
$412.17
|
-$54.04M
|
|
SEC
|
Fenimore Christopher R.
|
VP Controller
|
|
+150
|
$7.08
|
+$1.06K
|
|
SEC
|
Fenimore Christopher R.
|
VP Controller
|
|
+675
|
$190.23
|
+$128.41K
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
+152K
|
$138.94
|
+$21.17M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-86K
|
$0.03
|
-$2.57K
|
|
SEC
|
Landry Robert E
|
SVP Finance & CFO
|
|
-2.3K
|
$395.29
|
-$889.80K
|
|
SEC
|
Sanofi
|
N/A
|
|
-105K
|
$406.68
|
-$42.52M
|
|
SEC
|
Fenimore Christopher R.
|
VP Controller
|
|
+50
|
$21.25
|
+$1.06K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
+102
|
$141.21
|
+$14.40K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-610
|
$192.47
|
-$117.41K
|
|
SEC
|
Sanofi
|
N/A
|
|
-122K
|
$309.31
|
-$37.61M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-20K
|
$286.15
|
-$5.72M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-1.2K
|
$173.01
|
-$202.94K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-1K
|
$325.60
|
-$325.60K
|
|
SEC
|
Fenimore Christopher R.
|
VP Controller
|
|
+150
|
$21.25
|
+$3.19K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
+15K
|
$23.84
|
+$357.60K
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
+114K
|
$149.76
|
+$17.10M
|
|
SEC
|
YANCOPOULOS GEORGE
|
President & CSO
|
|
+89K
|
$149.76
|
+$13.37M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
+70K
|
$148.79
|
+$10.38M
|
|
SEC
|
Landry Robert E
|
SVP Finance & CFO
|
|
-663
|
$498.60
|
-$330.57K
|
|
SEC
|
Sanofi
|
N/A
|
|
+72K
|
$481.36
|
+$34.84M
|
|
SEC
|
Sanofi
|
N/A
|
|
+166K
|
$480.93
|
+$80.03M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-56K
|
$474.48
|
-$26.67M
|
|
SEC
|
Terifay Robert J
|
EVP Commercial
|
|
+1.9K
|
$52.03
|
+$99.95K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-29K
|
$146.81
|
-$4.23M
|
|
SEC
|
Sanofi
|
N/A
|
|
+136K
|
$478.17
|
+$65.06M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-10K
|
$408.95
|
-$4.26M
|
|
SEC
|
Sanofi
|
N/A
|
|
+87K
|
$369.71
|
+$32.27M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
+7K
|
$19.69
|
+$137.83K
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-3K
|
$392.02
|
-$1.18M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-2K
|
$429.34
|
-$858.68K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2.1K
|
$450.00
|
-$956.25K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2.1K
|
$425.00
|
-$903.13K
|
|
SEC
|
Sanofi
|
N/A
|
|
+65K
|
$363.86
|
+$23.55M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-1K
|
$396.64
|
-$396.64K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2K
|
$425.00
|
-$850.00K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2K
|
$400.00
|
-$800.00K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2K
|
$375.00
|
-$750.00K
|
|
SEC
|
Sanofi
|
N/A
|
|
+161K
|
$392.46
|
+$63.25M
|
|
SEC
|
Sanofi
|
N/A
|
|
+84K
|
$465.04
|
+$39.03M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-4K
|
$552.08
|
-$2.18M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-3K
|
$546.45
|
-$1.64M
|
|
SEC
|
YANCOPOULOS GEORGE
|
President Regeneron Laboratori
|
|
-43K
|
$549.03
|
-$23.80M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-3.5K
|
$580.00
|
-$2.03M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-17K
|
$587.90
|
-$10.14M
|
|
SEC
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
|
-5.1K
|
$554.85
|
-$2.84M
|
|
SEC
|
STAHL NEIL
|
EVP Research and Development
|
|
-42K
|
$561.45
|
-$23.64M
|
|
SEC
|
YANCOPOULOS GEORGE
|
President Regeneron Laboratori
|
|
-43K
|
$571.61
|
-$24.78M
|
|
SEC
|
Sanofi
|
N/A
|
|
+92K
|
$472.33
|
+$43.26M
|
|
SEC
|
Sanofi
|
N/A
|
|
+147K
|
$534.67
|
+$78.71M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-3K
|
$551.55
|
-$1.65M
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-5K
|
$550.00
|
-$2.75M
|
|
SEC
|
Powchik Peter
|
SVP Clinical Development & Reg
|
|
-23K
|
$573.38
|
-$13.47M
|
|
SEC
|
POON CHRISTINE A
|
N/A
|
|
-112
|
$564.16
|
-$63.19K
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-5K
|
$587.12
|
-$2.94M
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-13K
|
$588.97
|
-$7.91M
|
|
SEC
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
|
-4K
|
$584.36
|
-$2.35M
|
|
SEC
|
Landry Robert E
|
SVP Finance & CFO
|
|
-4K
|
$592.84
|
-$2.37M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-5K
|
$585.53
|
-$2.93M
|
|
SEC
|
Tessier-Lavigne Marc
|
N/A
|
|
-5K
|
$590.26
|
-$2.95M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2K
|
$586.00
|
-$1.17M
|
|
SEC
|
Sanofi
|
N/A
|
|
+11K
|
$537.48
|
+$5.72M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2K
|
$550.00
|
-$1.10M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2K
|
$526.85
|
-$1.05M
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
-1.4K
|
$513.39
|
-$707.96K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-5K
|
$515.00
|
-$2.58M
|
|
SEC
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
|
-18K
|
$508.42
|
-$9.34M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-4K
|
$514.28
|
-$2.06M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-13K
|
$515.60
|
-$6.70M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-5K
|
$495.00
|
-$2.48M
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-5K
|
$454.96
|
-$2.27M
|
|
SEC
|
Aberman Michael S
|
SVP Strategy Investor Relation
|
|
-4.8K
|
$478.99
|
-$2.32M
|
|
SEC
|
Aberman Michael S
|
SVP Strategy Investor Relation
|
|
-3.4K
|
$465.00
|
-$1.60M
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-11K
|
$451.01
|
-$4.96M
|
|
SEC
|
LAROSA JOSEPH J
|
SVP General Counsel and Secret
|
|
-18K
|
$450.00
|
-$8.24M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-3K
|
$416.24
|
-$1.25M
|
|
SEC
|
Tessier-Lavigne Marc
|
N/A
|
|
-3K
|
$421.95
|
-$1.27M
|
|
SEC
|
Aberman Michael S
|
SVP Strategy Investor Relation
|
|
-3.4K
|
$418.48
|
-$1.41M
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-11K
|
$423.67
|
-$4.73M
|
|
SEC
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
|
-9.4K
|
$427.82
|
-$4.03M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-1K
|
$422.72
|
-$422.72K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5K
|
$423.65
|
-$2.12M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-29K
|
$423.01
|
-$12.37M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-15K
|
$423.12
|
-$6.35M
|
|
SEC
|
Aberman Michael S
|
SVP Strategy Investor Relation
|
|
-3.7K
|
$404.46
|
-$1.49M
|
|
SEC
|
Powchik Peter
|
SVP Clinical Development & Reg
|
|
-11K
|
$414.08
|
-$4.48M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-1.5K
|
$410.58
|
-$615.87K
|
|
SEC
|
Sanofi
|
N/A
|
|
+201K
|
$393.21
|
+$79.22M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-8.5K
|
$410.15
|
-$3.48M
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-40K
|
$408.44
|
-$16.34M
|
|
SEC
|
STAHL NEIL
|
SVP Research and Development S
|
|
-5.3K
|
$412.93
|
-$2.19M
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-22K
|
$405.79
|
-$9.07M
|
|
SEC
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
|
-8.6K
|
$399.34
|
-$3.42M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5K
|
$398.31
|
-$1.99M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-46K
|
$400.30
|
-$18.34M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-3.5K
|
$400.11
|
-$1.38M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-69K
|
$404.01
|
-$27.92M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-5K
|
$399.00
|
-$2.00M
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Administration & Asst Secr
|
|
-27K
|
$400.70
|
-$10.73M
|
|
SEC
|
Sanofi
|
N/A
|
|
+122K
|
$335.35
|
+$40.96M
|
|
SEC
|
Sanofi
|
N/A
|
|
+158K
|
$328.16
|
+$51.97M
|
|
SEC
|
Sanofi
|
N/A
|
|
+32K
|
$349.26
|
+$11.08M
|
|
SEC
|
Sanofi
|
N/A
|
|
+141K
|
$345.15
|
+$48.54M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-10K
|
$350.07
|
-$3.62M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2K
|
$350.31
|
-$700.62K
|
|
SEC
|
Tessier-Lavigne Marc
|
N/A
|
|
-3K
|
$352.20
|
-$1.06M
|
|
SEC
|
Aberman Michael S
|
VP Strategy and Investor Relat
|
|
-3.6K
|
$350.00
|
-$1.26M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-5.9K
|
$353.00
|
-$2.07M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-3K
|
$349.20
|
-$1.05M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2K
|
$347.65
|
-$695.30K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-8K
|
$340.01
|
-$2.73M
|
|
SEC
|
STAHL NEIL
|
SVP Research and Development S
|
|
-12K
|
$339.96
|
-$3.96M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-12K
|
$340.11
|
-$4.07M
|
|
SEC
|
STAHL NEIL
|
SVP Research and Development S
|
|
-2.8K
|
$340.60
|
-$967.64K
|
|
SEC
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
|
-6.8K
|
$338.37
|
-$2.30M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2K
|
$331.20
|
-$662.40K
|
|
SEC
|
Sanofi
|
N/A
|
|
+129K
|
$314.92
|
+$40.66M
|
|
SEC
|
Sanofi
|
N/A
|
|
+300K
|
$316.80
|
+$95.04M
|
|
SEC
|
Sanofi
|
N/A
|
|
+175K
|
$311.08
|
+$54.44M
|
|
SEC
|
Sanofi
|
N/A
|
|
+348K
|
$309.76
|
+$107.80M
|
|
SEC
|
Sanofi
|
N/A
|
|
+357K
|
$312.37
|
+$111.42M
|
|
SEC
|
Sanofi
|
N/A
|
|
+212K
|
$307.25
|
+$65.26M
|
|
SEC
|
Sanofi
|
N/A
|
|
+212K
|
$300.20
|
+$63.76M
|
|
SEC
|
Sanofi
|
N/A
|
|
+262K
|
$281.17
|
+$73.78M
|
|
SEC
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
|
-5.4K
|
$295.93
|
-$1.59M
|
|
SEC
|
POON CHRISTINE A
|
N/A
|
|
+255
|
$291.90
|
+$74.43K
|
|
SEC
|
Sanofi
|
N/A
|
|
+191K
|
$300.04
|
+$57.23M
|
|
SEC
|
Sanofi
|
N/A
|
|
+307K
|
$306.73
|
+$94.15M
|
|
SEC
|
Sanofi
|
N/A
|
|
+307K
|
$311.01
|
+$95.46M
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-15K
|
$302.67
|
-$4.54M
|
|
SEC
|
Sanofi
|
N/A
|
|
+307K
|
$307.91
|
+$94.51M
|
|
SEC
|
Sanofi
|
N/A
|
|
+305K
|
$321.22
|
+$98.01M
|
|
SEC
|
Sanofi
|
N/A
|
|
+68K
|
$328.33
|
+$22.23M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-2K
|
$334.29
|
-$668.58K
|
|
SEC
|
Sanofi
|
N/A
|
|
+116K
|
$328.46
|
+$38.01M
|
|
SEC
|
Sanofi
|
N/A
|
|
+221K
|
$334.69
|
+$73.96M
|
|
SEC
|
Sanofi
|
N/A
|
|
+381K
|
$330.41
|
+$125.73M
|
|
SEC
|
Sanofi
|
N/A
|
|
+392K
|
$332.51
|
+$130.38M
|
|
SEC
|
Sanofi
|
N/A
|
|
+252K
|
$338.12
|
+$85.07M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-1K
|
$335.00
|
-$335.00K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Administration & Asst Secr
|
|
-12K
|
$339.55
|
-$4.03M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-1K
|
$338.86
|
-$338.86K
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-5K
|
$340.00
|
-$1.70M
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Administration & Asst Secr
|
|
-21K
|
$336.51
|
-$7.15M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-15K
|
$339.00
|
-$5.09M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-1K
|
$326.99
|
-$326.99K
|
|
SEC
|
Aberman Michael S
|
VP Strategy and Investor Relat
|
|
-3.6K
|
$331.42
|
-$1.21M
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-13K
|
$332.68
|
-$4.28M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-15K
|
$324.00
|
-$4.86M
|
|
SEC
|
STAHL NEIL
|
SVP Research and Development S
|
|
-23K
|
$318.82
|
-$7.21M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-1K
|
$320.62
|
-$320.62K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-15K
|
$320.52
|
-$4.81M
|
|
SEC
|
YANCOPOULOS GEORGE
|
President Regeneron Laboratori
|
|
-89K
|
$320.33
|
-$28.51M
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-5K
|
$320.00
|
-$1.60M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-5.8K
|
$325.00
|
-$1.89M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-11K
|
$325.10
|
-$3.73M
|
|
SEC
|
Sanofi
|
N/A
|
|
+169K
|
$286.78
|
+$48.33M
|
|
SEC
|
Sanofi
|
N/A
|
|
+397K
|
$284.12
|
+$112.87M
|
|
SEC
|
Sanofi
|
N/A
|
|
+209K
|
$283.78
|
+$59.30M
|
|
SEC
|
Sanofi
|
N/A
|
|
+158K
|
$275.90
|
+$43.57M
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-5K
|
$300.00
|
-$1.50M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-4K
|
$290.00
|
-$1.16M
|
|
SEC
|
Powchik Peter
|
SVP Clinical Development & Reg
|
|
-21K
|
$274.77
|
-$5.68M
|
|
SEC
|
Powchik Peter
|
SVP Clinical Development & Reg
|
|
-9.1K
|
$270.21
|
-$2.47M
|
|
SEC
|
Powchik Peter
|
SVP Clinical Development & Reg
|
|
-8
|
$270.00
|
-$2.16K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-95
|
$296.11
|
-$28.13K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-10K
|
$295.00
|
-$2.95M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-1K
|
$300.74
|
-$300.74K
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-9.2K
|
$313.82
|
-$2.88M
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-15K
|
$314.03
|
-$4.71M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-10K
|
$301.32
|
-$3.01M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-103K
|
$302.67
|
-$31.16M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-145K
|
$302.86
|
-$44.02M
|
|
SEC
|
ROBERTS WILLIAM
|
VP Reg Dev & Med Safety
|
|
-15K
|
$304.00
|
-$4.56M
|
|
SEC
|
Van Plew Daniel P
|
SVP & Gen Mgr IOPS
|
|
-24K
|
$303.17
|
-$7.27M
|
|
SEC
|
SCHLEIFER LEONARD S
|
CEO & President
|
|
-5K
|
$275.47
|
-$1.38M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-1K
|
$238.29
|
-$238.29K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-11K
|
$238.47
|
-$2.61M
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-15K
|
$251.84
|
-$3.78M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-2.5K
|
$249.55
|
-$623.88K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-4K
|
$252.20
|
-$1.01M
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO and
|
|
-67K
|
$259.74
|
-$17.36M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-15K
|
$275.19
|
-$4.13M
|
|
SEC
|
Aberman Michael S
|
VP Strategy and Investor Relat
|
|
-5.5K
|
$279.61
|
-$1.55M
|
|
SEC
|
STAHL NEIL
|
SVP Research and Development S
|
|
-23K
|
$276.88
|
-$6.38M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-5K
|
$270.00
|
-$1.35M
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-8.2K
|
$261.23
|
-$2.15M
|
|
SEC
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
|
-14K
|
$261.61
|
-$3.59M
|
|
SEC
|
YANCOPOULOS GEORGE
|
President Regeneron Laboratori
|
|
-100K
|
$262.64
|
-$26.26M
|
|
SEC
|
Aberman Michael S
|
VP Strategy and Investor Relat
|
|
-8.3K
|
$257.13
|
-$2.14M
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-30K
|
$261.04
|
-$7.83M
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-30K
|
$260.23
|
-$7.81M
|
|
SEC
|
Tessier-Lavigne Marc
|
N/A
|
|
-13K
|
$260.91
|
-$3.48M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-13K
|
$263.21
|
-$3.55M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller & Asst Treasurer
|
|
-2.2K
|
$244.79
|
-$541.72K
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-100K
|
$237.65
|
-$23.77M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-3.1K
|
$211.01
|
-$660.25K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5K
|
$180.00
|
-$900.00K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-15K
|
$173.27
|
-$2.60M
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-4.7K
|
$175.01
|
-$815.90K
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-92K
|
$175.33
|
-$16.07M
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-10K
|
$160.00
|
-$1.60M
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
|
-7.9K
|
$172.16
|
-$1.36M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5K
|
$185.00
|
-$925.00K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5K
|
$180.83
|
-$904.15K
|
|
SEC
|
Powchik Peter
|
SVP Clin Devel & Reg Affairs
|
|
-14K
|
$182.11
|
-$2.47M
|
|
SEC
|
Powchik Peter
|
SVP Clin Devel & Reg Affairs
|
|
-17K
|
$175.43
|
-$2.98M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller & Asst Treasurer
|
|
-2.6K
|
$176.47
|
-$457.59K
|
|
SEC
|
McCorkle Douglas S
|
VP Controller & Asst Treasurer
|
|
-1K
|
$179.20
|
-$179.20K
|
|
SEC
|
Aberman Michael S
|
VP Strategy and Investor Relat
|
|
-3.4K
|
$185.06
|
-$623.28K
|
|
SEC
|
Aberman Michael S
|
VP Strategy and Investor Relat
|
|
-3.9K
|
$180.64
|
-$705.22K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regulat Dev & Med Safety
|
|
-12K
|
$180.78
|
-$2.08M
|
|
SEC
|
STAHL NEIL
|
SVP Res and Devel Sciences
|
|
-17K
|
$181.01
|
-$3.11M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-5K
|
$185.00
|
-$925.00K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-86K
|
$179.10
|
-$15.34M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-65K
|
$175.22
|
-$11.35M
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-15K
|
$173.87
|
-$2.61M
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-9.7K
|
$174.45
|
-$1.70M
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-33K
|
$160.61
|
-$5.22M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-5K
|
$152.00
|
-$760.00K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-7K
|
$147.03
|
-$1.03M
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
|
-9.7K
|
$147.59
|
-$1.43M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-5K
|
$148.00
|
-$740.00K
|
|
SEC
|
Powchik Peter
|
SVP Clinical Development & Reg
|
|
-15K
|
$138.62
|
-$2.10M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-10K
|
$145.57
|
-$1.46M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-5K
|
$154.95
|
-$774.75K
|
|
SEC
|
Powchik Peter
|
SVP Clinical Development & Reg
|
|
-7.2K
|
$147.17
|
-$1.06M
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-15K
|
$150.00
|
-$2.25M
|
|
SEC
|
STAHL NEIL
|
SVP Research and Development S
|
|
-17K
|
$145.74
|
-$2.46M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-6.7K
|
$144.83
|
-$974.27K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regulatory Development and
|
|
-15K
|
$144.00
|
-$2.16M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-10K
|
$140.50
|
-$1.41M
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-10K
|
$136.15
|
-$1.36M
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-15K
|
$139.56
|
-$2.09M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-3K
|
$136.29
|
-$408.87K
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-24K
|
$135.91
|
-$3.24M
|
|
SEC
|
Powchik Peter
|
SVP Clinical Development & Reg
|
|
-7K
|
$130.64
|
-$916.96K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-5K
|
$135.00
|
-$675.00K
|
|
SEC
|
STAHL NEIL
|
SVP Res & Dev Sciences
|
|
-39K
|
$116.02
|
-$4.51M
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
-10K
|
$134.44
|
-$1.34M
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-20K
|
$123.73
|
-$2.47M
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
|
-32K
|
$135.40
|
-$4.28M
|
|
SEC
|
Aberman Michael S
|
VP Strategy and Investor Relat
|
|
-6.2K
|
$134.81
|
-$830.70K
|
|
SEC
|
SCHLEIFER LEONARD S
|
President & CEO
|
|
-100K
|
$134.83
|
-$13.48M
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP CSO President Regeneron Re
|
|
-33K
|
$134.83
|
-$4.47M
|
|
SEC
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
|
-14K
|
$136.38
|
-$1.97M
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-15K
|
$125.00
|
-$1.88M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5K
|
$120.00
|
-$600.00K
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP CSO President Regeneron Re
|
|
-33K
|
$120.24
|
-$3.99M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-10K
|
$112.90
|
-$1.13M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-20K
|
$103.26
|
-$2.07M
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-20K
|
$103.53
|
-$2.07M
|
|
SEC
|
Powchik Peter
|
SVP Clinical Development & Reg
|
|
-49K
|
$96.34
|
-$4.75M
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-19K
|
$109.61
|
-$2.08M
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-27K
|
$109.56
|
-$2.93M
|
|
SEC
|
STAHL NEIL
|
SVP Research and Development S
|
|
-52K
|
$109.21
|
-$5.71M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-15K
|
$110.02
|
-$1.65M
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
|
-18K
|
$99.88
|
-$1.75M
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
|
-18K
|
$91.76
|
-$1.68M
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-9.4K
|
$90.59
|
-$855.08K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
|
-17K
|
$77.96
|
-$1.34M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-10K
|
$80.00
|
-$800.00K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
-26K
|
$79.01
|
-$2.01M
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regulatory Development and
|
|
-32K
|
$75.46
|
-$2.39M
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-9K
|
$74.20
|
-$669.21K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-20K
|
$74.68
|
-$1.49M
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP, CSO & Pres, REGN Res Labs
|
|
-28K
|
$58.00
|
-$1.61M
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP CSO President Regeneron Re
|
|
-28K
|
$59.38
|
-$1.65M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-10K
|
$65.00
|
-$650.00K
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-7.2K
|
$65.32
|
-$471.22K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-5K
|
$78.00
|
-$390.00K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
|
-4.2K
|
$67.00
|
-$281.40K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
|
-7.5K
|
$67.81
|
-$511.42K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-10K
|
$71.50
|
-$715.00K
|
|
SEC
|
Aberman Michael S
|
VP Strategy and Investor Relat
|
|
-7.5K
|
$66.54
|
-$501.91K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
|
-14K
|
$69.73
|
-$943.52K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regulatory Development and
|
|
-23K
|
$67.32
|
-$1.55M
|
|
SEC
|
STAHL NEIL
|
SVP Research and Development S
|
|
-34K
|
$69.74
|
-$2.35M
|
|
SEC
|
SCHLEIFER LEONARD S
|
CEO & President
|
|
-7.9K
|
$66.03
|
-$521.64K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-92K
|
$61.11
|
-$5.65M
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
|
-6.4K
|
$56.85
|
-$364.35K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
|
-9.7K
|
$54.75
|
-$531.35K
|
|
SEC
|
Powchik Peter
|
SVP Clinical Development
|
|
-11K
|
$54.89
|
-$602.53K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regulatory Development and
|
|
-110
|
$56.70
|
-$6.24K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-658
|
$56.71
|
-$37.32K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regulatory Development and
|
|
-12K
|
$57.40
|
-$711.19K
|
|
SEC
|
VAGELOS P ROY
|
Chairman of the Board
|
|
-74K
|
$57.41
|
-$4.27M
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-11K
|
$57.13
|
-$628.43K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-25K
|
$56.28
|
-$1.41M
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-10K
|
$56.36
|
-$563.60K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5K
|
$48.89
|
-$244.45K
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-20K
|
$50.77
|
-$1.02M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-5K
|
$49.00
|
-$245.00K
|
|
SEC
|
STAHL NEIL
|
SVP Res and Dev Sciences
|
|
-34K
|
$46.10
|
-$1.57M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-3.3K
|
$44.65
|
-$147.75K
|
|
SEC
|
STAHL NEIL
|
SVP Res and Dev Sciences
|
|
-7.7K
|
$45.00
|
-$346.14K
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-1.7K
|
$38.97
|
-$66.25K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-8.1K
|
$39.65
|
-$320.93K
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-9.4K
|
$40.00
|
-$376.00K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-28K
|
$40.00
|
-$1.10M
|
|
SEC
|
Terifay Robert J
|
SVP Commercial
|
|
-6.1K
|
$38.00
|
-$231.76K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP F&A, CFO, Treas & Asst Sec
|
|
-5.9K
|
$37.32
|
-$219.63K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-2.8K
|
$36.66
|
-$101.22K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5.4K
|
$34.67
|
-$187.25K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regul Devel & Med Safety
|
|
-2.7K
|
$34.49
|
-$92.88K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-5.2K
|
$35.59
|
-$183.47K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regul Devel & Med Safety
|
|
-17K
|
$34.69
|
-$596.46K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-15K
|
$35.00
|
-$525.00K
|
|
SEC
|
Van Plew Daniel P
|
SVP & GM, Indust Ops&Prod Supp
|
|
-25K
|
$35.22
|
-$880.50K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP F&A, CFO, Treas & Asst Sec
|
|
-7.4K
|
$34.09
|
-$251.35K
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
-21K
|
$34.04
|
-$716.30K
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
-9K
|
$34.04
|
-$304.90K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-2.1K
|
$33.22
|
-$69.86K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP F&A, CFO, Treas & Asst Sec
|
|
-10K
|
$32.15
|
-$332.30K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5.3K
|
$32.00
|
-$168.99K
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
-30K
|
$32.05
|
-$961.50K
|
|
SEC
|
Van Plew Daniel P
|
SVP & GM, Indust Ops&Prod Supp
|
|
-25K
|
$32.00
|
-$800.00K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-4.3K
|
$30.06
|
-$130.19K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-7.5K
|
$30.00
|
-$225.00K
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
-30K
|
$30.03
|
-$900.90K
|
|
SEC
|
Sanofi-Aventis Amerique du Nord S.N.C.
|
N/A
|
|
+1M
|
$28.00
|
+$28.49M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-1.8K
|
$28.03
|
-$49.47K
|
|
SEC
|
RYAN ARTHUR F
|
N/A
|
|
+10K
|
$26.98
|
+$269.80K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP F&A, CFO, Treas & Asst Sec
|
|
-6.1K
|
$28.88
|
-$176.17K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-524
|
$27.73
|
-$14.53K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
+7.5K
|
$28.51
|
+$213.83K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-400
|
$28.06
|
-$11.22K
|
|
SEC
|
VAGELOS P ROY
|
N/A
|
|
-20K
|
$27.16
|
-$543.20K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-15K
|
$30.00
|
-$450.00K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP F&A, CFO, Treas & Asst Sec
|
|
-6.1K
|
$27.09
|
-$165.38K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regul Devel & Med Safety
|
|
-7.8K
|
$27.55
|
-$216.07K
|
|
SEC
|
KOLINSKI STUART
|
SVP General Counsel and Secret
|
|
-5.4K
|
$27.69
|
-$149.55K
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-5.9K
|
$28.00
|
-$164.50K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regul Devel & Med Safety
|
|
-2.1K
|
$26.56
|
-$56.28K
|
|
SEC
|
KOLINSKI STUART
|
SVP General Counsel and Secret
|
|
-4.4K
|
$27.00
|
-$117.69K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-15K
|
$26.00
|
-$390.00K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP F&A, CFO, Treas & Asst Sec
|
|
-13K
|
$24.88
|
-$316.18K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-15K
|
$25.00
|
-$375.00K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regul Devel & Med Safety
|
|
-13K
|
$23.99
|
-$299.88K
|
|
SEC
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
|
-2.5K
|
$22.00
|
-$54.03K
|
|
SEC
|
SING GEORGE L
|
N/A
|
|
+13K
|
$18.76
|
+$234.50K
|
|
SEC
|
SCHLEIFER LEONARD S
|
Chief Exec Officer & President
|
|
-30K
|
$16.52
|
-$495.60K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regul Devel & Med Safety
|
|
-14K
|
$23.49
|
-$332.76K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regul Devel & Clin Safety
|
|
-6.7K
|
$22.99
|
-$153.25K
|
|
SEC
|
STAHL NEIL
|
SVP Res and Dev Sciences
|
|
-37K
|
$20.55
|
-$769.04K
|
|
SEC
|
ROBERTS WILLIAM
|
VP Regul Devel & Clin Safety
|
|
-15K
|
$12.74
|
-$193.14K
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP, CSO, & Pres Regn Res Labs
|
|
-27K
|
$16.40
|
-$442.65K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-500
|
$22.32
|
-$11.16K
|
|
SEC
|
McCorkle Douglas S
|
VP, Controller and Asst. Treas
|
|
-16K
|
$21.74
|
-$355.06K
|
|
SEC
|
STAHL NEIL
|
SVP, Research & Devel Sciences
|
|
-10K
|
$21.63
|
-$223.16K
|
|
SEC
|
ROBERTS WILLIAM
|
VP, Regul Devel & Med Safety
|
|
-9.7K
|
$22.84
|
-$221.37K
|
|
SEC
|
KOLINSKI STUART
|
SVP, Gen Counsel & Secretary
|
|
-10K
|
$23.44
|
-$234.21K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-15K
|
$19.81
|
-$297.15K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-10K
|
$25.00
|
-$250.00K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5K
|
$25.00
|
-$125.00K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-6.7K
|
$19.77
|
-$132.62K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-9.4K
|
$20.47
|
-$192.42K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5K
|
$20.52
|
-$102.60K
|
|
SEC
|
McCorkle Douglas S
|
VP, Controller and Asst. Treas
|
|
-6.2K
|
$21.00
|
-$130.39K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-10K
|
$18.32
|
-$183.20K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Fin & Admin, CFO, & Treas
|
|
-8.9K
|
$27.08
|
-$241.85K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Fin & Admin, CFO, & Treas
|
|
-4.8K
|
$25.61
|
-$123.82K
|
|
SEC
|
STAHL NEIL
|
SVP, Research & Devel Sciences
|
|
-11K
|
$25.61
|
-$281.40K
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP, CSO, & Pres Regn Res Labs
|
|
-9.6K
|
$23.82
|
-$227.62K
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-10K
|
$21.55
|
-$215.50K
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-10K
|
$22.01
|
-$220.10K
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP, CSO, & Pres Regn Res Labs
|
|
-23K
|
$20.02
|
-$460.56K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-10K
|
$22.83
|
-$228.30K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Fin & Admin, CFO, & Treas
|
|
-23K
|
$23.67
|
-$541.14K
|
|
SEC
|
SCHLEIFER LEONARD S
|
Chief Exec Officer & President
|
|
-54K
|
$23.12
|
-$1.25M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-5K
|
$23.00
|
-$115.00K
|
|
SEC
|
STAHL NEIL
|
SVP, Therap & Clin Prog Dev
|
|
-47K
|
$20.02
|
-$949.93K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-4K
|
$20.00
|
-$80.00K
|
|
SEC
|
RUPP RANDALL
|
SVP, Manufuring Operations
|
|
-144K
|
$20.05
|
-$2.88M
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-4.5K
|
$18.67
|
-$83.44K
|
|
SEC
|
SCHLEIFER LEONARD S
|
Chief Exec Officer & President
|
|
-30K
|
$18.00
|
-$540.00K
|
|
SEC
|
RUPP RANDALL
|
SVP, Manufuring Operations
|
|
-23K
|
$15.71
|
-$368.57K
|
|
SEC
|
KOLINSKI STUART
|
VP, Gen Counsel & Secretary
|
|
-2K
|
$15.00
|
-$30.00K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-3.3K
|
$17.00
|
-$55.39K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-5.3K
|
$17.00
|
-$89.81K
|
|
SEC
|
SCHLEIFER LEONARD S
|
Chief Exec Officer & President
|
|
-1.1K
|
$18.00
|
-$19.82K
|
|
SEC
|
STAHL NEIL
|
SVP, PreclinDevel & Biomol Sci
|
|
-25K
|
$15.92
|
-$391.62K
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-10K
|
$15.34
|
-$153.40K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Fin & Admin, CFO, & Treas
|
|
-2.2K
|
$17.33
|
-$37.73K
|
|
SEC
|
KOLINSKI STUART
|
VP, Gen Counsel & Secretary
|
|
-1.6K
|
$17.33
|
-$28.09K
|
|
SEC
|
RUPP RANDALL
|
SVP, Manufuring Operations
|
|
-5.7K
|
$16.12
|
-$91.59K
|
|
SEC
|
STAHL NEIL
|
SVP, PreclinDevel & Biomol Sci
|
|
-1.7K
|
$17.33
|
-$30.22K
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP, CSO, & Pres Regn Res Labs
|
|
-900
|
$17.33
|
-$15.60K
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-10K
|
$16.46
|
-$164.60K
|
|
SEC
|
SHOOTER ERIC M
|
N/A
|
|
-2.4K
|
$15.89
|
-$38.23K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Fin & Admin, CFO, & Treas
|
|
-13K
|
$13.16
|
-$166.37K
|
|
SEC
|
KOLINSKI STUART
|
VP, Gen Counsel & Secretary
|
|
-3K
|
$15.00
|
-$45.00K
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP, CSO, & Pres Regn Res Labs
|
|
-5.5K
|
$14.88
|
-$81.84K
|
|
SEC
|
NOVARTIS PHARMA AG
|
N/A
|
|
-7.5M
|
$11.06
|
-$83.25M
|
|
SEC
|
STAHL NEIL
|
SVP, PreclinDevel & Biomol Sci
|
|
-11K
|
$9.47
|
-$101.11K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Fin & Admin, CFO, & Treas
|
|
-2.2K
|
$10.00
|
-$21.77K
|
|
SEC
|
KOLINSKI STUART
|
VP, Gen Counsel & Secretary
|
|
-1.6K
|
$9.49
|
-$15.38K
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-21K
|
$6.29
|
-$134.32K
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-10K
|
$6.52
|
-$65.20K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5K
|
$7.02
|
-$35.10K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-43K
|
$7.01
|
-$301.43K
|
|
SEC
|
GILMAN ALFRED G
|
N/A
|
|
-24K
|
$7.50
|
-$177.35K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-15K
|
$7.38
|
-$110.70K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-15K
|
$7.00
|
-$105.00K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-15K
|
$7.11
|
-$106.65K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-15K
|
$7.67
|
-$115.05K
|
|
SEC
|
RUPP RANDALL
|
SVP, Manuf & Process Sciences
|
|
-10K
|
$7.27
|
-$72.70K
|
|
SEC
|
RUPP RANDALL
|
SVP, Manuf & Process Sciences
|
|
-10K
|
$7.33
|
-$73.30K
|
|
SEC
|
RUPP RANDALL
|
SVP, Manuf & Process Sciences
|
|
-30K
|
$7.95
|
-$238.50K
|
|
SEC
|
GULER HANS PETER
|
VP Clinical Programs
|
|
-31K
|
$7.95
|
-$246.45K
|
|
SEC
|
KOLINSKI STUART
|
VP, Gen Counsel & Secretary
|
|
-855
|
$9.14
|
-$7.81K
|
|
SEC
|
GULER HANS PETER
|
VP Clinical Programs
|
|
-22K
|
$13.50
|
-$297.00K
|
|
SEC
|
BROWN MICHAEL S
|
N/A
|
|
-10K
|
$12.60
|
-$126.00K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-5K
|
$13.05
|
-$65.25K
|
|
SEC
|
BAKER CHARLES A
|
N/A
|
|
-5K
|
$14.80
|
-$74.00K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Fin & Admin, CFO, & Treas
|
|
-2.2K
|
$15.33
|
-$33.54K
|
|
SEC
|
KOLINSKI STUART
|
VP, Gen Counsel & Secretary
|
|
-1.6K
|
$15.33
|
-$23.99K
|
|
SEC
|
STAHL NEIL
|
SVP, PreclinDevel & Biomol Sci
|
|
-2.1K
|
$15.33
|
-$32.42K
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP, CSO, & Pres Regn Res Labs
|
|
-1.3K
|
$15.33
|
-$20.53K
|
|
SEC
|
GOLDSTEIN JOSEPH L
|
N/A
|
|
-13K
|
$14.51
|
-$188.63K
|
|
SEC
|
GOLDBERG MURRAY A
|
SVP Fin & Admin, CFO, & Treas
|
|
-15K
|
$20.74
|
-$311.10K
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP, CSO, & Pres Regn Res Labs
|
|
-26K
|
$20.75
|
-$543.88K
|
|
SEC
|
YANCOPOULOS GEORGE
|
EVP, CSO, & Pres Regn Res Labs
|
|
-50K
|
$20.43
|
-$1.02M
|
|
SEC
|
RUPP RANDALL
|
SVP, Manufacturing
|
|
-3.6K
|
$20.40
|
-$72.89K
|
|